Dietary fish oil reduces microthrombi over atherosclerotic lesions in hyperlipidemic swine even in the absence of plasma cholesterol reduction.
We have investigated in swine the effect of fish oil additives to a butter-cholesterol hyperlipidemic diet (BT) on atherogenesis and thrombogenesis when average plasma cholesterol levels were kept similar in fish oil-treated and untreated BT groups. The studies included evaluation of lesion sizes and cell numbers, counts of adherent monocytes over lesions, and counts of platelet clumps (microthrombi) over lesions either attached directly to endothelium or to adherent monocytes. Anatomic sites studied for lesion development were the left anterior descending coronary artery (LAD), the distal 1/5 of the abdominal aorta, and a proximal portion of the thoracic aorta. Counts of attached monocytes and platelet clumps were made by scanning electron microscopy only for the LAD and expressed per mm2 of surface. The most striking new result was in regard to the platelet clumps. These were reduced by the fish oil from 996 +/- 295/mm2 in the untreated BT group to 313 +/- 59 and 364 +/- 105 in BT+cod liver oil and BT+menhaden oil groups, respectively. Most of the platelet clumps were adherent to attached monocytes in all groups and the number of attached monocytes were greatly reduced by the fish oil additive. Thus there were close relationships among platelet clumps, monocytes, and lesion endothelium. Numbers of attachments over nonlesion endothelium were much less than those over lesions in all dietary groups. The most surprising result was the lack of retardation of lesion growth by the fish oil additives in spite of the reduction in attached monocytes and platelet clumps. In previous studies where the high plasma cholesterol levels in the BT swine had been modestly reduced (about 25%) there had been a marked retardation of lesion growth. The current result suggests that plasma cholesterol is the major factor controlling lesion growth in this model through under milder conditions and longer observation periods other factors might become apparent.
Kim
D N
DN
Department of Pathology and Laboratory Medicine, Albany Medical College, New York 12208.
Schmee
J
J
Baker
J E
JE
Lunden
G M
GM
Sheehan
C E
CE
Lee
C S
CS
Eastman
A
A
Solis
O
O
Ross
J S
JS
Thomas
W A
WA
D000818:Animals; D001011:Aorta / Q000473:pathology / Q000648:ultrastructure; D001158:Arteries / Q000473:pathology / Q000648:ultrastructure; D001161:Arteriosclerosis / Q000097:blood / Q000178:diet therapy* / Q000473:pathology; D001792:Blood Platelets / Q000473:pathology / Q000648:ultrastructure; D002452:Cell Count; D002784:Cholesterol / Q000097:blood*; D002791:Cholesterol, Dietary / Q000494:pharmacology; D003331:Coronary Vessels / Q000473:pathology / Q000648:ultrastructure; D004042:Dietary Fats, Unsaturated / Q000008:administration & dosage / Q000627:therapeutic use*; D004195:Disease Models, Animal; D004730:Endothelium, Vascular / Q000473:pathology / Q000648:ultrastructure; D005395:Fish Oils / Q000008:administration & dosage / Q000627:therapeutic use*; D006949:Hyperlipidemias / Q000097:blood / Q000209:etiology / Q000473:pathology*; D008297:Male; D008855:Microscopy, Electron, Scanning; D009000:Monocytes / Q000473:pathology / Q000648:ultrastructure; D010974:Platelet Aggregation; D013552:Swine / Q000378:metabolism*; D013927:Thrombosis / Q000097:blood / Q000178:diet therapy* / Q000473:pathology
D002791:Cholesterol, Dietary; D004042:Dietary Fats, Unsaturated; D005395:Fish Oils; D002784:Cholesterol